Cargando…
Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk
Lowering blood pressure and cholesterol, antiplatelet/antithrombotic use, and smoking cessation reduce risk of recurrent stroke. However, gaps in risk factor control among stroke survivors warrant development and evaluation of alternative care delivery models that aim to simultaneously improve multi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185059/ https://www.ncbi.nlm.nih.gov/pubmed/32200759 http://dx.doi.org/10.1161/STROKEAHA.119.027160 |
_version_ | 1783526692732534784 |
---|---|
author | Richards, Adam Jackson, Nicholas J. Cheng, Eric M. Bryg, Robert J. Brown, Arleen Towfighi, Amytis Sanossian, Nerses Barry, Frances Li, Ning Vickrey, Barbara G. |
author_facet | Richards, Adam Jackson, Nicholas J. Cheng, Eric M. Bryg, Robert J. Brown, Arleen Towfighi, Amytis Sanossian, Nerses Barry, Frances Li, Ning Vickrey, Barbara G. |
author_sort | Richards, Adam |
collection | PubMed |
description | Lowering blood pressure and cholesterol, antiplatelet/antithrombotic use, and smoking cessation reduce risk of recurrent stroke. However, gaps in risk factor control among stroke survivors warrant development and evaluation of alternative care delivery models that aim to simultaneously improve multiple risk factors. Randomized trials of care delivery models are rarely of sufficient duration or size to be powered for low-frequency outcomes such as observed recurrent stroke. This creates a need for tools to estimate how changes across multiple stroke risk factors reduce risk of recurrent stroke. METHODS—: We reviewed existing evidence of the efficacy of interventions addressing blood pressure reduction, cholesterol lowering, antiplatelet/antithrombotic use, and smoking cessation and extracted relative risks for each intervention. From this, we developed a tool to estimate reductions in recurrent stroke risk, using bootstrapping and simulation methods. We also calculated a modified Global Outcome Score representing the proportion of potential benefit (relative risk reduction) achieved if all 4 individual risk factors were optimally controlled. We applied the tool to estimate stroke risk reduction among 275 participants with complete 12-month follow-up data from a recently published randomized trial of a healthcare delivery model that targeted multiple stroke risk factors. RESULTS—: The recurrent stroke risk tool was feasible to apply, yielding an estimated reduction in the relative risk of ischemic stroke of 0.36 in both the experimental and usual care trial arms. Global Outcome Score results suggest that participants in both arms likely averted, on average, 45% of recurrent stroke events that could possibly have been prevented through maximal implementation of interventions for all 4 individual risk factors. CONCLUSIONS—: A stroke risk reduction tool facilitates estimation of the combined impact on vascular risk of improvements in multiple stroke risk factors and provides a summary outcome for studies testing alternative care models to prevent recurrent stroke. REGISTRATION—: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00861081. |
format | Online Article Text |
id | pubmed-7185059 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-71850592020-05-01 Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk Richards, Adam Jackson, Nicholas J. Cheng, Eric M. Bryg, Robert J. Brown, Arleen Towfighi, Amytis Sanossian, Nerses Barry, Frances Li, Ning Vickrey, Barbara G. Stroke Original Contributions Lowering blood pressure and cholesterol, antiplatelet/antithrombotic use, and smoking cessation reduce risk of recurrent stroke. However, gaps in risk factor control among stroke survivors warrant development and evaluation of alternative care delivery models that aim to simultaneously improve multiple risk factors. Randomized trials of care delivery models are rarely of sufficient duration or size to be powered for low-frequency outcomes such as observed recurrent stroke. This creates a need for tools to estimate how changes across multiple stroke risk factors reduce risk of recurrent stroke. METHODS—: We reviewed existing evidence of the efficacy of interventions addressing blood pressure reduction, cholesterol lowering, antiplatelet/antithrombotic use, and smoking cessation and extracted relative risks for each intervention. From this, we developed a tool to estimate reductions in recurrent stroke risk, using bootstrapping and simulation methods. We also calculated a modified Global Outcome Score representing the proportion of potential benefit (relative risk reduction) achieved if all 4 individual risk factors were optimally controlled. We applied the tool to estimate stroke risk reduction among 275 participants with complete 12-month follow-up data from a recently published randomized trial of a healthcare delivery model that targeted multiple stroke risk factors. RESULTS—: The recurrent stroke risk tool was feasible to apply, yielding an estimated reduction in the relative risk of ischemic stroke of 0.36 in both the experimental and usual care trial arms. Global Outcome Score results suggest that participants in both arms likely averted, on average, 45% of recurrent stroke events that could possibly have been prevented through maximal implementation of interventions for all 4 individual risk factors. CONCLUSIONS—: A stroke risk reduction tool facilitates estimation of the combined impact on vascular risk of improvements in multiple stroke risk factors and provides a summary outcome for studies testing alternative care models to prevent recurrent stroke. REGISTRATION—: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00861081. Lippincott Williams & Wilkins 2020-05 2020-03-23 /pmc/articles/PMC7185059/ /pubmed/32200759 http://dx.doi.org/10.1161/STROKEAHA.119.027160 Text en © 2020 The Authors. Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made. |
spellingShingle | Original Contributions Richards, Adam Jackson, Nicholas J. Cheng, Eric M. Bryg, Robert J. Brown, Arleen Towfighi, Amytis Sanossian, Nerses Barry, Frances Li, Ning Vickrey, Barbara G. Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk |
title | Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk |
title_full | Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk |
title_fullStr | Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk |
title_full_unstemmed | Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk |
title_short | Derivation and Application of a Tool to Estimate Benefits From Multiple Therapies That Reduce Recurrent Stroke Risk |
title_sort | derivation and application of a tool to estimate benefits from multiple therapies that reduce recurrent stroke risk |
topic | Original Contributions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185059/ https://www.ncbi.nlm.nih.gov/pubmed/32200759 http://dx.doi.org/10.1161/STROKEAHA.119.027160 |
work_keys_str_mv | AT richardsadam derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk AT jacksonnicholasj derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk AT chengericm derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk AT brygrobertj derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk AT brownarleen derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk AT towfighiamytis derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk AT sanossiannerses derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk AT barryfrances derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk AT lining derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk AT vickreybarbarag derivationandapplicationofatooltoestimatebenefitsfrommultipletherapiesthatreducerecurrentstrokerisk |